Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sumei Slim Patch is a proprietary transdermal weight loss product developed by China Sky One Medical, Inc. and its subsidiary Harbin Tian Di Ren. Marketed under the brand name 'Sleep & Slim' (Shui-shui Shou), the patch contains active ingredients extracted from traditional Chinese herbs. It is indicated for simple obesity and is designed to be applied topically to the skin, with marketing claims emphasizing weight loss during sleep. The product was a major commercial success for China Sky One Medical and was exported to international markets such as South Korea and Sudan. However, it has faced significant controversy regarding the validity of its advertising claims and reports of adverse skin reactions, including inflammation, swelling, and ulcers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sumei Slim Patch.